With Taiwan recording one of the highest per capita rates of dialysis patients globally, the demand for smarter and more efficient treatment models is growing rapidly. Cardiovascular complications, especially heart failure during hemodialysis, pose serious and often unpredictable threats. Traditional interventions rely heavily on physician intuition and manual observation, placing immense pressure on medical staff. The healthcare industry urgently needs innovative tools to enhance treatment accuracy and reduce the burden on medical staff. AI-powered solutions are revolutionizing clinical care by combining real-time physiological data with predictive analytics for proactive patient monitoring and management.
To elevate dialysis risk prediction and care optimization, Portwell and Muen Biomedical and Optoelectronic Technologies have joined forces to develop a real-time, AI-driven hemodialysis monitoring solution. By combining Portwell’s industrial computing expertise with Muen’s AI medical analytics, the joint solution enables early cardiovascular risk detection and precise dry weight calculation. This integrated system, designed to provide physicians with real-time insights, ensures faster intervention and reduces clinical guesswork. Combining hardware reliability with leading-edge machine learning (ML) algorithms, the solution enhances treatment accuracy and streamlines hospital operations.
Muen’s AI engine processes real-time data from hemodialysis machines, including arterial and venous pressure, blood flow rate, patient medical history, medications, and lab results. Leveraging advanced time-series analysis, it predicts heart failure risk and recommends ideal dry weight levels, boosting estimation accuracy from 80% to 90%. The AI platform visualizes machine data and predictive metrics in real-time, enabling staff to monitor trends and intervene early. This system facilitates a significant shift from reactive to preventive care, enhancing safety and improving outcomes for high-risk dialysis patients.
Central to this innovation is Portwell’s MEDS-P1600, a medical-grade panel PC designed with edge AI computation capabilities. Powered by the energy-efficient Intel® Celeron® J6413 processor, it offers reliable performance for handling large volumes of real-time data. Its 15.6-inch FHD touchscreen supports intuitive interaction—even with gloves—while IP65-rated durability guarantees reliability in hospital settings. With dual 2.5GbE LAN, multiple USB ports, and wireless modules, MEDS-P1600 ensures seamless integration with medical information systems. This robust platform enables standalone inference and centralized data sharing, facilitating scalable deployment across dialysis centers.
The Portwell-Muen AI solution provides clinicians with accurate, real-time decision-making tools. The MEDS-P1600 captures and processes data directly at the bedside, running AI models locally for immediate inference and transmitting results to a central nursing station for broader oversight. This synergy greatly reduces manual workload, facilitates early risk identification, and improves fluid management accuracy. The solution is fundamental to smarter dialysis workflows, paving the way for scalable applications in smart hospitals, chronic disease management, and intensive care units.
Portwell and Muen’s collaboration showcases the transformative power of edge AI in modern healthcare. By integrating medical-grade embedded computing with healthcare AI, the partnership underscores a shared commitment to advancing digital healthcare transformation. The intelligent hemodialysis solution supports smarter treatment strategies and establishes a foundation for predictive and personalized medicine in real-time. Through ongoing innovation, Portwell and Muen aim to empower care providers with tools that enhance patient outcomes and optimize operational efficiency in the evolving “AI Next” medical landscape.